欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是

中国临床药理学与治疗学 ›› 2010, Vol. 15 ›› Issue (3): 251-254.

• 专论 • 上一篇    下一篇

利奈唑胺、万古霉素对甲氧西林耐药的金黄色葡萄球菌的防耐药突变体选择浓度的研究

梁蓓蓓, 王睿, 白楠, 蔡芸   

  1. 解放军总医院临床药理研究室, 北京100853
  • 收稿日期:2010-01-07 修回日期:2010-01-30 发布日期:2020-10-14
  • 通讯作者: 王睿, 女, 博导, 研究方向为抗菌药物临床药理学。Tel:010-66937909 E-mai l:wangrui301 @vip.sina.com

Mutant prevention concentrations study of linezolid and vancomycin against methicillin-resistant staphylococcus aureus isolates

LIANG Bei-bei, WANG Rui, BAI Nan, CAI Yun   

  1. Department of Clinical Pharmacology, General Hospi tal of PLA, Beijing 100853, China
  • Received:2010-01-07 Revised:2010-01-30 Published:2020-10-14

摘要: 目的: 比较利奈唑胺、万古霉素对耐甲氧西林金黄色葡萄球菌的防耐药突变选择能力;研究防耐药突变体选择浓度(MPC) 和最低抑菌浓度(MIC) 的相关性 。方法: 采用琼脂微量稀释法测定利奈唑胺、万古霉素对35 株耐甲氧西林金黄色葡萄球菌(MRSA) 临床分离菌株的MPC 和MIC ;采用线性回归法比较利奈唑胺、万古霉素对MRSA 的MPC 和MIC 的相关性;结合人体药代动力学数据, 预测利奈唑胺、万古霉素对MRSA的防耐药突变体选择能力 。结果: 利奈唑胺、万古霉素对35 株MRSA 的MPC90值(抑制90 %的细菌发生细菌耐药的最低防耐药突变体选择浓度)分别为16、8 μg/mL, 选择指数(MPC90 /MIC90)均为8 。两药对M RSA 的MPC 和MIC 的线性相关系数R 2分别为0.32 和0.008 。结合两药药代动力学参数, 利奈唑胺药物浓度在整个给药间隔落在耐药突变选择窗理论(MSW) 中, 万古霉素药物浓度在大部分给药间隔落在MPC 之上 。结论: 万古霉素对MRSA 的防耐药选择能力强于利奈唑胺;MPC 和MIC 的相关性差。

关键词: 利奈唑胺, 万古霉素, 甲氧西林耐药金黄色葡萄球菌, 防耐药突变突变体选择浓度

Abstract: AIM: To compare the mutant prevention concentration (MPC) of linezolid and vancomycin against methicillin resistant staphylococcus aureus (MRSA) and study the correlation between minimal inhibitory concentration (MIC) and MPC. METHODS:MICs and MPCs of two drugs against 35 MRSA clinical stains we re determined by agar plates dilution method.The correlations between MIC and MPC were determined by linear regression.The ability to rest rict the resi stance was evaluated according the pharmaco kinetics of two drugs. RESULTS: The MPCs of two drugs against MRSA were 16 and 8 μg/mL and the MPC/MIC was 8.MPCs and MICs correlated poo rly (R 2 were 0.32 and 0.008, respectively).According to pharmacokinetics of two drugs, the concentration of linezolid was inside the MSW (mutant selective window) for the entire dosage interval, while the concentration of vancomycin exceeded the MPC for the most do sage interval. CONCLUSION: The capacity of vancomycin for rest ricting the selection of MRSA resistant mutants is stronger than that of linezolid.There is low correlation between MPC and MIC.

Key words: Linezolid, Vancomycin, Methicillin resistant staphylococcus aureus, Mutantprev ention concentration

中图分类号: